arrow
Back
M

Mark E. Robson

Memorial Sloan Kettering Cancer Center

115H-index
956Paper Count
5.8WCitation Count
Published Papers 314
Publication Date
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 Variants
err2026-05-21
err0
errOAAI
errGiulia Ongaro; Caroline Salafia; Rania Sheikh; Elizabeth Schofield; Dana Farengo Clark; Jessica Ebrahimzadeh; Anu Chittenden; Jill E. Stopfer; Jamie Brower; Heather Symecko; Hannah Ovadia; Alexander Husband; Hadley Barr; Semanti Mukherjee; Jennifer L. Hay; Zsofia K. Stadler; Kenneth Offit; Judy E. Garber; Susan M. Domchek; Mark E. Robson
errShare
errSave
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
errNature
IF48.5
err2026-03-04
err0
errOAAI
errAnton Safonov; Minna Lee; David N. Brown; Luca Boscolo Bielo; Miika Mehine; Chaitanya Bandlamudi; Ben O’Leary; Hong Shao; Laia Vicente; Daniel Muldoon; Allen Zhu; Susana Ros; Antonio Marra; Pier Selenica; Ivan Bieche; Bradley Wubbenhorst; Emanuela Ferraro; Laura Courtois; Rania El Botty; Mehnaj Ahmed; Enrico Moiso; Julia Ah-Reum An; Mark T. A. Donoghue; Marie Will; Fresia Pareja; Emily Nizialek; Natalia Lukashchuk; Eleni Sofianopoulou; Yuan Liu; Xin Huang; Colombe Chappey; Anna D. Staniszewska; Dara Ross; Diana Mandelker; Marc Ladanyi; Nikolaus Schultz; Michael F. Berger; Maurizio Scaltriti; Jorge S. Reis-Filho; Bob T. Li; Kenneth Offit; Larry Norton; Ronglai Shen; Kara N. Maxwell; Fergus Couch; Susan M. Domchek; Elisabetta Marangoni; Sohrab Shah; Mark R. Albertella; Violeta Serra; Britta Weigelt; David B. Solit; Katherine L. Nathanson; Mark E. Robson; Nicholas C. Turner; Sarat Chandarlapaty; Pedram Razavi
errShare
errSave
Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial
err2025-12-19
err0
PREAI
errP.S. Schmid; H.L. McArthur; J. Cortés; B. Xu; F. Cardoso; M. Casalnuovo; U. Demirci; R. Freitas-Junior; J. Ghosh; R. Hegg; H. Iwata; I. Karnaukhov; Y.L. Chuken; M. Nechaeva; M.E. Robson; R. Villalobos-Valencia; T. Yamashita; B. Zurawski; E.C. de Bruin; L. Grinsted
errShare
errSave
Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer
err2025-10-02
err0
errOAAI
errNour Abuhadra; Fresia Pareja; Charlie White; Yuan Chen; Hannah Wen; Esra Dikoglu; Jinae Park; Stephanie Downs-Canner; Larry Norton; George Plitas; Atif Khan; Sarat Chandarlapaty; Pedram Razavi; Mark Robson; Monica Morrow; Giacomo Montagna
errShare
errSave
Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA status
err2025-08-22
err0
PREAI
errJay A Andersen; Jagadeswara Rao Earla; Nicole Fulcher; Juliet Ndukum; Nicholas Robert; Mark E Robson; Weiyan Li; Jaime Mejia
errShare
errSave
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer
err2025-08-14
err0
errOAAI
errJuan C. Osorio; David A. Knorr; Polina Weitzenfeld; Lucas Blanchard; Ning Yao; Maria Baez; Carlo Sevilla; Meghan DiLillo; Jahan Rahman; Ved P. Sharma; Jacqueline Bromberg; Michael A. Postow; Charlotte Ariyan; Mark E. Robson; Jeffrey V. Ravetch
errShare
errSave
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
err2025-08-07
err0
errOAAI
errGiovanni Corso; Sherry Shen; Carmen Criscitiello; Rita Mukhtar; Lauren Gamble; Elena Guerini Rocco; Filippo Pesapane; Luca Nicosia; Komal Jhaveri; Beatrice Taurelli Salimbeni; Giulia Massari; Eleonora Meduri; Alessandra Margherita De Scalzi; Alberto Concardi; Francesca Magnoni; Anita Mamtani; Fresia Pareja; Maria Cristina Leonardi; Virgilio Sacchini; Giorgio Bogani; Carlo La Vecchia; Daniele Presti; Marco Angelo Colleoni; Paolo Veronesi; Mark E. Robson
errShare
errSave
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncology
err2025-07-01
err0
PREAI
errHung, Tony K. W.; Mao, Jun J.; Ho, Alan L.; Sherman, Eric J.; Robson, Mark; Park, Jae; Stein, Eytan M.; Kuperman, Gilad J.; Pfister, David G.
errShare
errSave
Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendations
err2025-06-15
err0
PREAI
errC. Turnbull; M.I. Achatz; J. Balmaña; E. Castro; G. Curigliano; C. Cybulski; S.M. Domchek; D.G. Evans; H. Hanson; N. Hoogerbrugge; P.A. James; A. Krause; K.L. Nathanson; J. Ngeow Yuen Yie; M. Robson; M. Tischkowitz; B. Westphalen; W.D. Foulkes
errShare
errSave
Breast Cancer Susceptibility Gene Sequence Variations and Development of Contralateral Breast Cancer
err2024-12-30
err1
errOAAI
errReiner, Anne S.; Watt, Gordon P.; Malone, Kathleen E.; Lynch, Charles F.; John, Esther M.; Knight, Julia A.; Woods, Meghan; Liang, Xiaolin; Tischkowitz, Marc; Conti, David V.; Robson, Mark E.; Mellemkjaer, Lene; Teraoka, Sharon N.; Concannon, Patrick; Bernstein, Jonine L.
errShare
errSave
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis
err2024-12-16
err0
errOAAI
errEarla, Jagadeswara R.; Kurian, Allison W.; Kponee-Shovein, Kale; Mahendran, Malena; Song, Yan; Hua, Qi; Hilts, Annalise; Sun, Yezhou; Hirshfield, Kim M.; Robson, Mark; Mejia, Jaime A.
errShare
errSave
Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
err2024-10-28
err0
errOAAI
errChew, S. M.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D.; Modi, S.; Seidman, A. D.; Wen, H.; Brogi, E.; Robson, M.; Dang, C. T.
errShare
errSave
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
err2024-10-18
err1
errOAAI
errMai, Nicholas; dos Anjos, Carlos H.; Razavi, Pedram; Safonov, Anton; Patil, Sujata; Chen, Yuan; Drago, Joshua Z.; Modi, Shanu; Bromberg, Jacqueline F.; Dang, Chau T.; Liu, Dazhi; Norton, Larry; Robson, Mark; Chandarlapaty, Sarat; Jhaveri, Komal
errShare
errSave
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing
err2024-10-01
err2
errOAAI
errRowlands, C. F.; Allen, S.; Balmana, J.; Domchek, S. M.; Evans, D. G.; Hanson, H.; Hoogerbrugge, N.; James, P. A.; Nathanson, K. L.; Robson, M.; Tischkowitz, M.; Foulkes, W. D.; Turnbull, C.
errShare
errSave
The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review
err2024-10-01
err0
PREAI
errAbu Remilah, Areen; Krayim, Bilal; Amir, Eitan; Tibau, Ariadna; Robson, Mark E.; Abuhadra, Nour; Chen, Yuan; Shepshelovich, Daniel; Goldvaser, Hadar
errShare
errSave
Capivasertib (C) plus paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer (mTNBC): The CAPItello-290 phase III trial
err2024-09-01
err2
PREAI
errSchmid, P.; McArthur, H. L.; Cortes, J.; Xu, B.; Cardoso, F.; Casalnuovo, M. L.; Demirci, U.; Freitas, R., Jr.; Ghosh, J.; Hegg, R.; Iwata, H.; Chuken, Y. A. Lopez; Nechaeva, M.; Robson, M. E.; Villalobos Valencia, R.; Lloyd, A.; D'Cruz, C.; Foxley, A.; Park, Y. H.
errShare
errSave
Enhanced Recovery in Cranial Surgery (ERACraS) - a Single-Centre Qualitative Improvement Study
err2024-08-29
err0
PREAI
errAbul, M. H.; Sescu, D.; White, M. A.; Robson, M.; Ferguson, J.; McDermott, F.; Kaliaperumal, C.
errShare
errSave
Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes
err2024-08-01
err1
PREAI
errChew, Sonya M.; Ferraro, Emanuela; Safonov, Anton; Chen, Yuan; Kelly, Daniel; Razavi, Pedram; Robson, Mark; Seidman, Andrew D.
errShare
errSave
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer
err2024-07-28
err0
errOAAI
errMai, Nicholas; Chen, Jie-Fu; Rana, Satshil; Robson, Mark; Chandarlapaty, Sarat; Rosen, Ezra Y.
errShare
errSave
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers
err2024-07-26
err1
errOAAI
errMyers, Sara P.; Sevilimedu, Varadan; Barrio, Andrea V.; Tadros, Audree B.; Mamtani, Anita; Robson, Mark E.; Morrow, Monica; Lee, Minna K.
errShare
errSave